Rescuing primary cilia may also have therapeutic benefit to patients with established disease by enabling tumour epithelial cells to regulate ectopic Hh activation through expression of negative regulators such as Ptch1 (Cervantes et al., 2010). This evidence concerns the gene PTCH1 and neoplasm.